Steroid Dependent Acute GvHD: An Interprofessional Approach
Program Overview
Acute graft-versus-host disease (aGvHD) is a common complication of allogenic hematopoietic stem cell transplant (allo-HSCT). Corticosteroids, usually at high doses, comprise the mainstay of first-line treatment for most patients, but can often be intolerable due to adverse events and the development of steroid-dependent disease. In this activity, an interprofessional expert panel discusses a physician-submitted case of a 45-year-old man who developed steroid-dependent aGvHD after undergoing an allo-HSCT for high-risk acute myelogenous leukemia (AML). The panel will provide insight and input from a medical, pharmacy, and PA perspective.
Upon completion of this activity, participants should be better able to:
Integrate the unique roles and responsibilities of interprofessional care team members when managing hematopoietic stem cell transplant (HSCT) recipients with acute graft-versus-host disease (aGvHD)
Activity Faculty
Carrie L. Kitko, MD
Associate Professor, Pediatrics and Hematology/Oncology Ingram Professorship, Pediatric Oncology, Department of Pediatrics Medical Director, Pediatric Stem Cell Transplantation Program
Vanderbilt University Medical Center
Nashville, TN
Katie S. Gatwood, PharmD, BCOP
Clinical Pharmacist Specialist, Stem Cell Transplant & Cellular Therapy
Vanderbilt University Medical Center
Nashville, TN
Christine Yennaco, PA-C, MPH, MCHS
Associate Director, Advanced Practice Providers – BMT & Immunotherapy
Fred Hutchinson Cancer Center Teaching Associate, UW Medicine
University of Washington
Seattle, WA